ReplyThe Department is committed to ensuring that all patients, including those with dementia, have access to cutting-edge clinical trials and innovative, lifesaving treatments.The Department funds research and research infrastructure through the National Institute for Health and Care Research (NIHR) which supports National Health Service patients, the public, and NHS organisations across England to participate in high-quality research, including clinical trials into dementia.The Department, via the NIHR, is also investing nearly £50 million into the Dementia Trials Network, a coordinated network of trial sites across the United Kingdom, which will offer people with dementia the opportunity to take part in early phase clinical trials irrespective of where they live. This is complemented by the £20 million Dementia Trials Accelerator, designed to position the United Kingdom as the destination of choice for late phase clinical trials in dementia and neurodegenerative diseases.In partnership with Alzheimer’s Society, Alzheimer’s Research UK, and Alzheimer Scotland, the NIHR delivers Join Dementia Research, an online platform which enables the involvement of people with and without a dementia diagnosis, as well as carers, to take part in a range of important research, including studies evaluating potential treatments for dementia.The NIHR also provides an online service called 'Be Part of Research', which promotes participation in health and social care research by allowing users to search for relevant studies, including those with dementia, and register their interest.The NIHR South Central Regional Research Delivery Network supports the delivery of dementia studies and increased patient participation and timely access to clinical trials for NHS organisations serving the Didcot and Wantage constituency, this is complemented by NIHR Biomedical Research Centres, including the NIHR Oxford Biomedical Research Centre in developing cognitive, imaging and blood-based biomarkers that support earlier detection.